This year's ViVE conference featured a variety of news announcements — from company launches to new products to partnerships to acquisitions and more. In this list, MedCity News compiled short summaries for nine of the conference's most notable announcements.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions. Learn More.
The future of American healthcare hinges on the continued support and elevation of independent primary care—a cornerstone that not only enhances healthcare quality and cost controls but also ensures a healthier and more equitable future for all.
March is Lymphedema Awareness Month, and today there are more options than ever to help prevent this challenging and all too common complication associated with breast cancer treatment.
By implementing workforce management technology to support the people who take care of the patients, health systems can ensure that merger and acquisition activity is a success.
A federal judge disagreed with AstraZeneca's claims that the Inflation Reduction Act causes harm by disincentivizing innovation and violates its constitutional rights to due process. Blockbuster AstraZeneca drug Farxiga is one of 10 medications selected for the Medicare drug price negotiation program created by the law.
For this episode of the MedCity Moves Podcast, Katie Adams chats with Adam Petrich, who recently became QuantHealth's first chief medical officer. Learn more about Petrich's career journey in the pharmaceutical world and why he made the move to QuantHealth.
No comments